These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29398121)

  • 1. Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease.
    Blauwendraat C; Kia DA; Pihlstrøm L; Gan-Or Z; Lesage S; Gibbs JR; Ding J; Alcalay RN; Hassin-Baer S; Pittman AM; Brooks J; Edsall C; Chung SJ; Goldwurm S; Toft M; Schulte C; ; Hernandez D; Singleton AB; Nalls MA; Brice A; Scholz SW; Wood NW
    Neurobiol Aging; 2018 Apr; 64():159.e5-159.e8. PubMed ID: 29398121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.
    Hoffman-Zacharska D; Koziorowski D; Ross OA; Milewski M; Poznanski JA; Jurek M; Wszolek ZK; Soto-Ortolaza A; Awek JAS; Janik P; Jamrozik Z; Potulska-Chromik A; Jasinska-Myga B; Opala G; Krygowska-Wajs A; Czyzewski K; Dickson DW; Bal J; Friedman A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1057-1060. PubMed ID: 23916651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
    Kiely AP; Ling H; Asi YT; Kara E; Proukakis C; Schapira AH; Morris HR; Roberts HC; Lubbe S; Limousin P; Lewis PA; Lees AJ; Quinn N; Hardy J; Love S; Revesz T; Houlden H; Holton JL
    Mol Neurodegener; 2015 Aug; 10():41. PubMed ID: 26306801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
    Appel-Cresswell S; Vilarino-Guell C; Encarnacion M; Sherman H; Yu I; Shah B; Weir D; Thompson C; Szu-Tu C; Trinh J; Aasly JO; Rajput A; Rajput AH; Jon Stoessl A; Farrer MJ
    Mov Disord; 2013 Jun; 28(6):811-3. PubMed ID: 23457019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of alpha-synuclein mutations.
    Kasten M; Klein C
    Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous alpha-synuclein p.A53V in familial Parkinson's disease.
    Yoshino H; Hirano M; Stoessl AJ; Imamichi Y; Ikeda A; Li Y; Funayama M; Yamada I; Nakamura Y; Sossi V; Farrer MJ; Nishioka K; Hattori N
    Neurobiol Aging; 2017 Sep; 57():248.e7-248.e12. PubMed ID: 28666710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population scale analysis of rare SNCA variation in the UK Biobank.
    Blauwendraat C; Makarious MB; Leonard HL; Bandres-Ciga S; Iwaki H; Nalls MA; Noyce AJ; Singleton AB
    Neurobiol Dis; 2021 Jan; 148():105182. PubMed ID: 33307186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease.
    Fevga C; Park Y; Lohmann E; Kievit AJ; Breedveld GJ; Ferraro F; de Boer L; van Minkelen R; Hanagasi H; Boon A; Wang W; Petsko GA; Hoang QQ; Emre M; Bonifati V
    Parkinsonism Relat Disord; 2021 Aug; 89():63-72. PubMed ID: 34229155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel α-synuclein missense mutation in Parkinson disease.
    Proukakis C; Dudzik CG; Brier T; MacKay DS; Cooper JM; Millhauser GL; Houlden H; Schapira AH
    Neurology; 2013 Mar; 80(11):1062-4. PubMed ID: 23427326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at onset in LRRK2-associated PD is modified by SNCA variants.
    Botta-Orfila T; Ezquerra M; Pastor P; Fernández-Santiago R; Pont-Sunyer C; Compta Y; Lorenzo-Betancor O; Samaranch L; Martí MJ; Valldeoriola F; Calopa M; Fernández M; Aguilar M; de Fabregas O; Hernández-Vara J; Tolosa E
    J Mol Neurosci; 2012 Sep; 48(1):245-7. PubMed ID: 22669510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease.
    Deng S; Deng X; Yuan L; Song Z; Yang Z; Xiong W; Deng H
    Acta Neurol Belg; 2015 Sep; 115(3):267-71. PubMed ID: 25092551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.
    Proukakis C; Houlden H; Schapira AH
    Mov Disord; 2013 Jun; 28(6):705-12. PubMed ID: 23674490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.
    Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB
    Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort.
    Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B
    Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.